BACKGROUND AND OBJECTIVE: This study evaluated the efficacy and durability of faricimab in patients with neovascular age-related macular degeneration (nAMD) who were previously treated with anti-vascular endothelial growth factor (anti-VEGF) agents
Bibliographische Detailangaben
| Veröffentlicht in: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 55(2024), 9 vom: 01. Sept., Seite 504-509
|
|---|
| 1. Verfasser: |
Shaheen, Abdulla
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Ashkenazy, Noy,
Magraner, Maria,
Patel, Nimesh A,
Fortun, Jorge,
Rosenfeld, Philip J,
Schwartz, Stephen G,
Haddock, Luis J,
Dubovy, Sander R,
Sridhar, Jayanth,
Yehoshua, Zohar,
Kovach, Jaclyn L,
Townsend, Justin H,
Smiddy, William E,
Flynn, Harry W Jr,
Yannuzzi, Nicolas A |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2024
|
|---|
| Zugriff auf das übergeordnete Werk: | Ophthalmic surgery, lasers & imaging retina
|
|---|
| Schlagworte: | Journal Article
Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
VEGFA protein, human
Ranibizumab
ZL1R02VT79
Antibodies, Monoclonal, Humanized
Immunoglobulin Fab Fragments |
|---|